Trial Profile
Effects of Defibrotide as Prophylaxis of Liver Toxicity During Allogeneic Hsc Transplantation in Patients with Acute Leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Defibrotide (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 17 Dec 2015 New trial record